We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-4.45%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.08B
AUM Growth
+$322M
Cap. Flow
+$648M
Cap. Flow %
21%
Top 10 Hldgs %
37.4%
Holding
321
New
89
Increased
78
Reduced
45
Closed
96

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32M
2
CCCC icon
C4 Therapeutics
CCCC
+$14.5M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$14.1M
4
AMRS
Amyris Inc.
AMRS
+$11M
5
TECH icon
Bio-Techne
TECH
+$10.3M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$14.1M
2
DXCM icon
DexCom
DXCM
+$14.1M
3
ICUI icon
ICU Medical
ICUI
+$14M
4
LIVN icon
LivaNova
LIVN
+$12.2M
5
OLPX
Olaplex Holdings
OLPX
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 24.06%
2 Materials 0.35%
3 Industrials 0.17%
4 Consumer Discretionary 0.07%
5 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTD icon
51
PUT
Mettler-Toledo International
MTD
$28.8B
$15.1M 0.49%
11,000
+1,300
+13% +$1.88M
LUNG icon
52
Pulmonx
LUNG
$98.4M
$14.6M 0.47%
589,722
+109,634
+23% +$2.83M
ISEE
53
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$14.6M 0.47%
865,144
-24,310
-3% -$359K
RMD icon
54
PUT
ResMed
RMD
$32.8B
$13.9M 0.45%
+57,500
New +$13.9M
LUNG icon
55
CALL
Pulmonx
LUNG
$98.4M
$13.8M 0.45%
554,700
-10,900
-2% -$282K
STAA icon
56
PUT
STAAR Surgical
STAA
$1.27B
$13.6M 0.44%
170,000
+9,900
+6% +$737K
BMRN icon
57
BioMarin Pharmaceuticals
BMRN
$13.6B
$13.5M 0.44%
175,356
+5,146
+3% +$431K
CLDX icon
58
CALL
Celldex Therapeutics
CLDX
$3.52B
$13.5M 0.44%
396,600
+2,300
+0.6% +$73.5K
IRTC icon
59
CALL
iRhythm Holdings
IRTC
$4.13B
$13.4M 0.43%
85,000
-33,500
-28% -$4.3M
ICUI icon
60
CALL
ICU Medical
ICUI
$4.48B
$13.3M 0.43%
59,600
-9,400
-14% -$2.11M
CNMD icon
61
PUT
CONMED
CNMD
$1.48B
$13.2M 0.43%
89,000
-19,400
-18% -$2.71M
OEF icon
62
CALL
iShares S&P 100 ETF
OEF
$20.4B
$13M 0.42%
+100,000
New +$20.5M
ICUI icon
63
ICU Medical
ICUI
$4.48B
$12.8M 0.42%
57,700
-62,276
-52% -$14M
NVST icon
64
PUT
Envista
NVST
$4.61B
$12.7M 0.41%
+260,000
New +$12M
CVS icon
65
PUT
CVS Health
CVS
$121B
$12.5M 0.41%
+123,700
New +$13M
LNTH icon
66
Lantheus
LNTH
$6.57B
$12.3M 0.4%
222,238
-73,457
-25% -$2.76M
PACB icon
67
PUT
Pacific Biosciences
PACB
$345M
$12.3M 0.4%
1,350,000
+772,900
+134% +$8.9M
QTNT
68
DELISTED
Quotient Limited Ordinary Shares
QTNT
$12.2M 0.4%
253,935
+37,675
+17% +$2.25M
HQY icon
69
CALL
HealthEquity
HQY
$8.82B
$12.1M 0.39%
+180,000
New +$9.72M
TAP icon
70
PUT
Molson Coors Class B
TAP
$7.75B
$11.7M 0.38%
+218,300
New +$11M
CNVY
71
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$11.3M 0.37%
1,720,752
+244,674
+17% +$1.61M
TMO icon
72
PUT
Thermo Fisher Scientific
TMO
$223B
$11.2M 0.36%
19,000
-6,000
-24% -$3.45M
NTRA icon
73
CALL
Natera
NTRA
$45.5B
$11.2M 0.36%
+275,000
New +$16.5M
AVTR icon
74
PUT
Avantor
AVTR
$9.42B
$11M 0.36%
+325,000
New +$11.6M
TECH icon
75
Bio-Techne
TECH
$11.3B
$10.8M 0.35%
+100,000
New +$10.3M
1 2
3
4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Pura Vida Investments held 321 positions worth $3.08B, up 12% from $2.76B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Pura Vida Investments deployed $648M of net new capital in Q1 2022, opening 89 new positions and adding to 78 existing holdings. Its largest new stake was Biogen: 147,135 shares worth $31M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 30% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was ICU Medical, an estimated $14M trimmed.

  • Pura Vida Investments's largest Q1 2022 buy was Biogen: 147,135 shares worth $31M.
  • Pura Vida Investments added most to C4 Therapeutics in Q1 2022, an estimated $14.5M increase.
  • Pura Vida Investments's biggest Q1 2022 reduction was ICU Medical, cutting an estimated $14M.
  • Pura Vida Investments fully exited Natera in Q1 2022, selling an estimated $14.1M.
  • Pura Vida Investments's ten largest holdings make up 37% of its $3.08B portfolio in Q1 2022.
  • Pura Vida Investments opened 89 new positions and closed 96 in Q1 2022.
  • Pura Vida Investments's portfolio value rose 12% quarter-over-quarter to $3.08B.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.